Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
Patients with inflammatory bowel disease (IBD) have an increased risk of colon cancer. However, the immune cells and cytokines that mediate the transition from intestinal inflammation to cancer are poorly understood. We show that bacteria-induced colon cancer is accompanied by differential accumulation of IL-17(+)IL-22(+) colonic innate lymphoid cells (cILCs), which are phenotypically distinct from LTi and NK-22 cells, and that their depletion in mice with dysplastic inflammation blocks the development of invasive colon cancer. Analysis of the functional role of distinct Type 17 cytokines shows that although blockade of IL-17 inhibits some parameters of intestinal inflammation, reduction in dysplasia and colorectal cancer (CRC) requires neutralization of IL-22 indicating a unique role for IL-22 in the maintenance of cancer in this model. Mechanistic analyses showed that IL-22 selectively acts on epithelial cells to induce Stat3 phosphorylation and proliferation. Importantly, we could detect IL-22(+)CD3(+) and IL-22(+)CD3(−) cells in human CRC. Our results describe a new activity of IL-22 in the colon as a nonredundant mediator of the inflammatory cascade required for perpetuation of CRC, highlighting the IL-22 axis as a novel therapeutic target in colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although known to exert a tumor-promoting effect in colorectal cancer (Kirchberger et al., 2013; Wang et al., 2017)”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Kirchberger et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039 · cited 1×
“…in many mouse models (Hue et al., 2006; Izcue et al., 2008), and its components IL-23R and Stat3 are not only associated with IBD susceptibility (Duerr et al., 2006; Barrett et al., 2008) but also involved in inflammation-associated cancer in the skin and colon (Langowski et al., 2006; Bollrath…”
BackgroundThe risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959 · cited 1×
“In inflammatory bowel disease (IBD) patients, deranged inflammatory responses toward the intestinal microbiota increase the risk of colon cancer twofold (Eaden et al., 2001).”
BackgroundGenome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593 · cited 1×
“…(Hue et al., 2006; Izcue et al., 2008), and its components IL-23R and Stat3 are not only associated with IBD susceptibility (Duerr et al., 2006; Barrett et al., 2008) but also involved in inflammation-associated cancer in the skin and colon (Langowski et al., 2006; Bollrath et al., 2009;…”
BackgroundLiang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 8×
“It is now appreciated that a Type 17 cytokine expression signature is not restricted to Th-17 cells, and that cytokines such as IL-17 and IL-22 can be produced by unconventional T cell populations and more recently described RORtexpressing innate lymphoid populations (Pearson et al., 2012).”
BackgroundInfluentialCrypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166 · cited 1×
“IL-22 may also promote cancer through direct effects on intestinal epithelial stem cells, previously shown to be key precursors for intestinal cancer (Barker et al., 2009).”
BackgroundGrivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155 · cited 2×
“The role of Stat3 in colon cancer is well known but this has been attributed to activation by IL-6 and IL-11 (Ernst et al., 2008; Grivennikov et al., 2009).”
BackgroundFusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043 · cited 1×
“Furthermore, certain species like the anaerobic Fusobacterium nucleatum were found to be associated with human CRC tissue (Castellarin et al., 2012; Kostic et al., 2012).”
BackgroundGenomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960 · cited 1×
“Furthermore, certain species like the anaerobic Fusobacterium nucleatum were found to be associated with human CRC tissue (Castellarin et al., 2012; Kostic et al., 2012).”
BackgroundInterleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
Zheng, Y., Valdez, P. A., Danilenko, D. M., Hu, Y., Sa, S. M., Gong, Q., Abbas, A. R., Modrusan, Z., Ghilardi, N., de Sauvage, F. J., et al. (2008) · Nature Medicine · doi:10.1038/nm1720 · Cited by 1,921 · cited 8×
“IL-23 also drives colon cancer in an APC model, where it is induced in tumor-associated myeloid 928 Interleukin-22 in colon cancer | Kirchberger et al. (Reference numbers: 11/YH/0020 and 09/H0606/5) and informed written consent was given by all study patients.”
BackgroundInfluentialWu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812 · cited 3×
“Th17 cell infiltration was also found in animal models of colon cancer, such as the ApcMin model driven by the enterotoxigenic bacterium Bacteroides fragilis, where blockade of IL-17 decreased tumor incidence (Wu et al., 2009).”
Background
Cited by
Items 401–500 of 529
Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review)
Zhang, J., Feng, Y., Li, D., & Shi, D. (2024) · Oncology Letters · doi:10.3892/ol.2024.14796 · Cited by 10
The crosstalk between ILC3s and adaptive immunity in diseases
Wang, W., Li, N., & Guo, X. (2023) · FEBS Journal · doi:10.1111/febs.17014 · Cited by 12
“For instance, IL-22 derived from ILC3s sustained colon cancer in a Helicobacter hepaticus -AOM induced cancer model by modulating epithelial functions through STAT3 activation [79].”
Foronjy, R. (2020) · Bioscience Reports · doi:10.1042/bsr20190768 · Cited by 8
“Innate lymphoid cells confer protection against infection (26) and promote tissue repair (27) but their aberrant activation induces asthma (28), autoimmune injury (29) and cancer (30).”
BackgroundThe interaction network between group 3 innate lymphoid cells and other cells
Hu, Y.-T., Liu, X.-Z., Zhang, Y., & Guo, X. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.10.021 · Cited by 8
“ILC3-produced IL-22 may induce abnormal proliferation of IECs and thus function in the transition from chronic inflammation to colon cancer as well as the perpetuation of cancer [16] .”
Enteric nervous system and inflammatory bowel disease
Wang, S., Wang, Y., Miao, J., Zheng, X., Ge, W., Chen, G., & Yin, Y. B. (2026) · Gastroenterology report · doi:10.1093/gastro/goag005 · Cited by 9
“Research has increasingly focused on how these interactions might contribute to the pathogenesis of gastrointestinal diseases, including IBD and colorectal cancer [151–153].”
Impact of gut microbiota and its metabolites on immunometabolism in colorectal cancer
Flory, M., Bravo, P., & Alam, A. M. (2024) · Immunometabolism · doi:10.1097/in9.0000000000000050 · Cited by 11
Clostridioides difficile Toxin B Activates Group 3 Innate Lymphocytes
Pope, R. L., Chitrakar, A., Sah, P., Shadid, T. M., Ballard, J. D., & Zenewicz, L. A. (2022) · Infection and Immunity · doi:10.1128/iai.00073-22 · Cited by 8
Multifaceted nature of natural killer cells: Potential mode of interaction and shaping of stem cells
Senjor, E., Ko, M.-W., Kaur, K., Chen, P.-C., Breznik, B., Chovatiya, N., Kos, J., & Jewett, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822620-9.00020-3 · Cited by 10
Progression or suppression: Two sides of the innate lymphoid cells in cancer
Hosseini, S. H., Sharafkandi, N., Seyfizadeh, N., Hemmatzadeh, M., Marofi, F., Shomali, N., Karimi, M., & Mohammadi, H. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29503 · Cited by 7
“ILC3s play a crucial role in cancer prevention, as is shown in a colon cancer mouse model induced by bacteria in which IL‐22 production via NCR‐ILC3 is a vital factor.(56) Other research studies confirmed that expression of IL‐23 transgene could promote the rapid development of Helicobacter, carcinogens independently,…”
BackgroundInfluentialThe reciprocal regulation between autophagy and IL-22: implications for immunity and therapy
Yu, Y., Qiao, M., Liu, J., Guo, Y., & Sun, Y. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01695-y · Cited by 6
“While it has been found to contribute to cancer progression during prolonged inflammation [107], IL-22 also has potential antitumor properties, as observed in some experimental models.”
Helper innate lymphoid cells as cell therapy for cancer
Magnusson, F. C., & Bahhar, I. (2022) · Immunology · doi:10.1111/imm.13599 · Cited by 5
“Other reports of ILC3 cells as promoting cancer development include Helicobacter hepaticus driven colorectal cancer, where IL-22 is found to be essential for tumour progression and is secreted mainly by CCR6+ ILC3 cells [68], as well as human and mouse breast cancer where ILC3 cell numbers are increased in tumour tiss…”
BackgroundDisease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells
Mori, A., Ohno, H., & Satoh‐Takayama, N. (2024) · Seminars in Immunopathology · doi:10.1007/s00281-024-01000-1 · Cited by 6
“Given the fact that ILCs accumulate in the intestines of IBD patients, it was hypothesized that ILCs may be involved in the tumorigenesis in intestinal cancer, and most likely ILC3s, IL-17, and IL-22, which are cytokines produced by ILC3s, were shown to be associated with tumorigenesis [65].”
Ondondo, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00090 · Cited by 6
Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?
Weinberg, F. D., & Ramnath, N. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.09.04 · Cited by 5
Isolation of mononuclear phagocytes from the mouse gut
Chiaranunt, P., Burrows, K., Ngai, L., & Mortha, A. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.10.004 · Cited by 6
Droeser, R. A., & Iezzi, G. (2021) · Journal of Cellular Immunology · doi:10.33696/immunology.3.087 · Cited by 9
Pivotal Roles of ILCs in Hepatic Diseases
Yang, S. C., Tian, Z., Wu, Y., van Velkinburgh, J. C., & Ni, B. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1008631 · Cited by 6
“observed accumulation of resident IL-17+IL-22+ ILCs in a mouse model of bacteria-induced colon cancer and indicated the pro-tumorigenic potential of these cells when their depletion inhibited development of invasive colon cancer [92].”
BackgroundPathological and therapeutic roles of innate lymphoid cells in diverse diseases
Kim, J., Kim, G., & Min, H. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0974-2 · Cited by 7
“In addition, an increase in IL-22 production is observed in human CRC tissue (Jiang et al. 2013; Kirchberger et al. 2013).”
BackgroundThe role of helper innate lymphoid cells in cancer
Hu, S., & Wang, X. (2019) · Immunotherapy · doi:10.2217/imt-2019-0048 · Cited by 6
Li, S., Xie, M., Du, Y., & Tan, Z. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02235-7 · Cited by 7
“IL‐22, IL‐17/IL‐23, IL‐6 knockdown have shown to have potential anti-colorectal cancer effects through inhibiting inflammation and oncogenic pathways [59, 63].”
Ruan, H.-X., Fang, Y.-L., Qin, X.-N., & Lin, L. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i8.108535 · Cited by 5
IL-22 regulates MASTL expression in intestinal epithelial cells
Pravoverov, K., Fatima, I., Barman, S., Jühling, F., Primeaux, M., Baumert, T. F., Singh, A. B., & Dhawan, P. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00260.2023 · Cited by 6
Interleukin‐22: friend or foe?
Hasnain, S. Z., & Begun, J. (2019) · Immunology and Cell Biology · doi:10.1111/imcb.12249 · Cited by 5
Gut microbiota and immunology of the gastrointestinal tract
Manley, G. C. A., Lee, Y. K., & Zhang, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813037-7.00004-2 · Cited by 9
The Potential of Dendritic-Cell-Based Vaccines to Modulate Type 3 Innate Lymphoid Cell Populations
Chan, L., Mehrani, Y., Minott, J. A., Bridle, B. W., & Karimi, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032403 · Cited by 5
“However, in a model of bacteria-induced colon cancer, it was demonstrated that IL-17 and IL-22 from ILCs in the colon contributed to the development of the colon cancer [23].”
BackgroundIL-22BP controls the progression of liver metastasis in colorectal cancer
Giannou, A. D., Kempski, J., Zhang, T., Lücke, J., Shiri, A. M., Zazara, D. E., Belios, I., Machicote, A., Seeger, P., Agalioti, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1170502 · Cited by 4
“IL-22 expression is upregulated in CRC and is associated with chemotherapy resistance (10, 11, 13, 29).”
BackgroundVisual analysis of colorectal cancer and gut microbiota: A bibliometric analysis from 2002 to 2022
Long, D., Mao, C., Zhang, Z., Zou, J., & Zhu, Y. (2023) · Medicine · doi:10.1097/md.0000000000035727 · Cited by 4
“[56,58] NLRP6 inflammasome participates in the release of IL-18 through IECs, promotes chemokine CCL5 production, and secretes a large amount of IL-6 to aggravate the level of intestinal inflammation and induce CRC. [59] Interestingly, YAO Xiaomin et al found that the NLRP3-R258W mutation could…”
BackgroundGao, J., Wei, J., Qin, S., Liu, S., Mo, S., Qian, L., Tan, S., Lu, N., Xie, Z., & Lin, J. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01693-7 · Cited by 4
Cancer Immunosurveillance by Natural Killer Cells and Other Innate Lymphoid Cells
Guillerey, C., & Smyth, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_9 · Cited by 5
Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression
Raja, R., Wu, C. W., Limbeck, F., Butler, K. A., Acharya, A. P., & Curtis, M. (2021) · Cancers · doi:10.3390/cancers13133327 · Cited by 4
Cellular Cosmetics: How Innate Lymphoid Cells Can Recontour the Tumour Microenvironment
Pun, N., & Withers, D. R. (2025) · European Journal of Immunology · doi:10.1002/eji.70041 · Cited by 4
Dinh, T. T., Lordo, M. R., Zhang, A. Y., Goda, C., Shilo, N., Altynova, E. S., Ruesch, M., Kronen, P., Broughton, M. J., Jeremy, E. G., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02829-7 · Cited by 4
Wang, X., Mei, W., Wang, Z., Ma, M., Wang, J., Ji, J., & Xing, X. (2026) · The Innovation · doi:10.1016/j.xinn.2026.101300 · Cited by 4
“155 Additionally, IL-22-binding protein produced by DCs contributes to reduced tumorigenesis and decreased epithelial cell proliferation in the colon.”
Zhao, Y., Sui, J.-F., Wu, D., Chen, M., Ni, J., Zhang, Y., Xin, S.-Y., & Fan, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1682356 · Cited by 5
Gut microbiota and macrophage crosstalk: implications for colitis-associated colorectal cancer
Lyu, W., Zhang, Z., Liu, L., Sun, Y., Wang, B., Zhou, C., Liu, Z., & Feng, B. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1778244 · Cited by 5
“IL-22 strengthens the intestinal mucosal barrier and promotes epithelial repair by activating the STAT3 signaling pathway in epithelial cells, leading to the production of antimicrobial peptides such as RegIII g , mucins, and chemokines (Kirchberger et al., 2013).”
Parallels Between Mammals and Flies in Inflammatory Bowel Disease
Christofi, T., & Apidianakis, Y. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-18326-8_7 · Cited by 3
“In fact, STAT3 pathway lies at the intersection of inflammationand regeneration because innate immune cells secrete its ligands, IL6 and IL22, to induce epithelial regeneration in the nearby cells (Grivennikov et al. 2009; Kirchberger et al. 2013; Kryczek et al. 2014).”
BackgroundSmith, K. J., Sciumè, G., & Amarnath, S. (2023) · Discovery Immunology · doi:10.1093/discim/kyad003 · Cited by 3
“In bacteria-induced colon cancer, IL-17 and IL-22-producing colonic ILCs are involved in driving pro-tumor responses; specifically, IL-22 sustains inflammation during cancer by STAT3 phosphorylation in epithelial cells inducing proliferation [68].”
BackgroundControversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy
Zhang, Y., Feng, X.-F., Chen, J., Liu, J.-H., Wu, J.-M., Tan, H.-P., Mi, Z., & Rong, P.-F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1134636 · Cited by 3
Role of innate lymphoid cells in cancer metastasis
Moreno-Vicente, J., & Halim, T. Y. F. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106465 · Cited by 3
Čelakovská, J., Čermáková, E., Boudková, P., & Krejsek, J. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2299721 · Cited by 3
Ge, Z., Ge, L., Muthupalani, S., Feng, Y., & Fox, J. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238886 · Cited by 3
“In another study, anti-Il-22 but not anti-Il-17 treatment significantly reduced the incidence rate of colorectal cancer in Hh+AOM-treated 129Rag2−/− mice [26].”
BackgroundInnate Lymphoid Cells in Mucosal Homeostasis, Infections, Autoimmune Disorders, and Tumors
Colonna, M., Fuchs, A. G., & Cella, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00052-5 · Cited by 3
Vasoactive intestinal peptide confers anticipatory mucosal immunity by regulating ILC3 activityPreprint
Seillet, C., Luong, K., Tellier, J., Jacquelot, N., Shen, R. D., Hickey, P. F., Wimmer, V. C., Whitehead, L. W., Rogers, K. L., Smyth, G. K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/729400 · Cited by 3
Drinking vinegar, a potential adjuvant for immunotherapy of HCC?
Hou, J. (2022) · Hepatology · doi:10.1002/hep.32463 · Cited by 3
Innate lymphoid cells: Dual roles and therapeutic opportunities in breast cancer
Mojić, M., Ilić, N., Bobić, S., Radenković, S., Cruz‐Adalia, A., & Stojanović, I. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107051 · Cited by 2
Innate lymphoid cells and gastrointestinal disease
Wang, Z., & Wang, J. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.08.004 · Cited by 2
Nakatani, A., Okumura, R., Ishibashi, A., Okamoto, S., Sakaki, K., Ito, Y., Okuzaki, D., Inohara, H., & Takeda, K. (2023) · Genes to Cells · doi:10.1111/gtc.13065 · Cited by 2
“…promotes the proliferation of intestinal epithelial cells through in vitro experiments using organoids and in vivo experiments, such as via treatment with recombinant IL-22, mucosal injury models, and cancer models (Aparicio-Domingo et al., 2015; Kirchberger et al., 2013; Lindemans et al., 2015).”
BackgroundOncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review
Guardamagna, M., Meyer, M., Berciano‐Guerrero, M., Mesas-Ruiz, A., Cobo, M., Pérez-Ruiz, E., Cantero, A., Lavado-Valenzuela, R., Barragán, I., Oliver, J., et al. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-216 · Cited by 2
Immunology and Immunotherapy of Colorectal Cancer
Varela‐Calviño, R., & Cordero, O. J. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_11 · Cited by 2
Profile of interleukin-22 in gut mucosal health and disease
Sousa, A. E., Foxall, R. B., & Fernandes, S. M. (2016) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s64856 · Cited by 4
“The fact that chronic intestinal inflammation is a widely accepted risk factor for CRC development 134 and that, as discussed earlier, IL-22 is upregulated in the context of IBD provides strong circumstantial evidence of a role of this cytokine in CRC.”
BackgroundInfluentialThe college health education course: its status and future.
Richardson, C. (1974) · PubMed · Cited by 2
Intestinal Stem Cells and Their Defining Niche
Trentesaux, C., & Romagnolo, B. (2018) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2017.12.003 · Cited by 3
Innate Lymphoid Cells for the Control of Mucosal Immunity
Longman, R., Metz, M. L., & Artis, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00014-6 · Cited by 3
Lymphoid like stromal cells in a model of tertiary lymphoid organ formation
Nayar, S. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
RNF43 is a gatekeeper for colitis-associated cancerPreprint
Dietl, A., Ralser, A., Taxauer, K., Dregelies, T., Sterlacci, W., Stadler, M., Olayo-Alarcón, R., Margaryan, S., Skerhut, M., Groll, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.30.577936 · Cited by 2
Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progression
Yin, X., Geng, R., Chen, J., Xu, B., Ma, H., Liu, Y., Zheng, X., & Chen, L. (2025) · BMC Cancer · doi:10.1186/s12885-025-14715-7 · Cited by 1
Ghezel, M. A., Aram, C., Alishvandi, A., Barancheshmeh, M., Firuzpour, F., Khodabandehloo, M. H., Mohammadian, S., Rahimi, M., & Keikha, M. (2026) · Translational research · doi:10.1016/j.trsl.2026.03.001 · Cited by 2
Sasse, R., & Mejias-Beck, J. (2026) · Digestive Diseases and Sciences · doi:10.1007/s10620-026-09986-4 · Cited by 1
“IL-22 neutralization in bacteria-induced CAC reduces epithelial STAT3 activation and cyclin D1 expression despite only modest effects on granulocyte infiltration, highlighting a direct epithelial axis [232].”
Interleukin-1 Superfamily and Cancer
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00002-6 · Cited by 2
Bisson, W. H., Amedei, A., Memeo, L., Forte, S., & Felsher, D. W. (2017) · John Wiley & Sons, Inc. eBooks · doi:10.1002/9781119023647.ch14 · Cited by 2
Les cellules innées lymphoïdes : des nouveaux acteurs de l’immunité
Cypowyj, S., & Vivier, É. (2016) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30732-0 · Cited by 5
“Il a également été montré que les ILC3 NCR joueraient un rôle dans le développement de colite dans des modèles d’IBD [32].”
BackgroundPositive and Negative Effects of the Commensal Bacteria on Carcinogenesis
Lafta, I. J., & Alkaabawi, N. A. M. (2019) · Sudan Journal of Medical Sciences · doi:10.18502/sjms.v14i2.4688 · Cited by 1
Theodoropoulos, G. E. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_4 · Cited by 1
Keykhosravi, M., Javadzadeh, S. M., Tehrani, M., Asgarian‐Omran, H., Rashidi, M., Hossein‐Nataj, H., Vahedi‐Larijani, L., & Ajami, A. (2023) · Comparative Clinical Pathology · doi:10.1007/s00580-023-03462-5 · Cited by 2
The Microbiome and Innate Immunity: Role in the Tumor Microenvironment
Bueno-Urquiza, L. J., Martínez-Barajas, M. G., Pereira-Suárez, A. L., Villegas‐Mercado, C. E., & Bermúdez, M. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_367 · Cited by 1
Immunologic Response in the Host
Madsen, K. L., & Park, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00026-4 · Cited by 2
Role of microbiome in cancer immunotherapy
Russo, E., Boem, F., & Amedei, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00010-7 · Cited by 1
Inoue, N., & Akazawa, T. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/46016
Inflammation and Antimicrobial Defense in the Intestine
Caballero, S., & Pamer, E. G. (2015)
colitis-associated innate lymphoid cell production of IL-22
Longman, R., Diehl, G. E., Victorio, D., Huh, J. R., Galan, C., Miraldi, E. R., Swaminath, A. C., Bonneau, R., Scherl, E., & Littman, D. R. (2014)
Microbiome Implications in Intestinal Tumorigenesis
Posocco, D. F., Dmitrieva, O., & Grivennikov, S. I. (2015) · Springer eBooks · doi:10.1007/978-3-319-19986-3_7
Innate Lymphoid Cells: Roles In Tumour Genesis And Progression
Jovanović, I., Gajović, N., Radosavljevic, G. D., Pantic, J. M., Pejnovic, N. N., Arsenijević, N., & Lukić, M. L. (2015) · Serbian Journal of Experimental and Clinical Research · doi:10.1515/sjecr-2015-0011
“Recent studies described the involvement of ILCs in tumour growth and progression (8-11).”
BackgroundThe IL-20 Subfamily of Cytokines and Their Receptors
Rutz, S., Wang, X., Eidenschenk, C., Ota, N., & Ouyang, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10017-7
Belz, G. T., Rankin, L. C., Carotta, S., Romagnani, C., & Huntington, N. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.04004-2
Dryden, G. W. (2016) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/2374
Acker, A. V. (2016) · Ghent University Academic Bibliography (Ghent University)
The role of interleukin-22 in the mouse model of malaria infection, Plasmodium chabaudi
Kouassi, V. (2016) · UCL Discovery (University College London)
Innate Lymphoid Cells and Infection
Song, C. (2017) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2017.47.2.105
“ILC3는 숙주의 병리현상을 가속시키기도 하는데, 예를 들면 ILC3가 생성하는 IL-22가 Helicobacter hepaticus에 감 염된 Rag-/- 마우스의 경우 대장암을 유발하는 등 종양을 촉진하는데 기여하기도 한다 (27).”
Inflammatory Biomarkers for Cancer
Corthay, A., & Haraldsen, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-39147-2_10 · Cited by 1
Group 2 and 3 Innate Lymphoid Cells: New Actors in Immunity and Inflammation
Serafini, N., & Santo, J. P. D. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch14
Exploration of immunogene in colon cancer recurrence
Sun, Q.-R., Chen, Y., Yuan, S., & Liao, J. (2018) · Oncotarget · doi:10.18632/oncotarget.24218
“In some cases, immune cells constitute an additional, prominent component of the host response to cancer, but their participation in tumour pathogenesis remains incompletely understood [8].”
BackgroundBeumer, J. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/125
Innate Lymphoide Zellen – gewebespezifische Regulatoren von Homöostase und Immunität
Friedrich, C., & Gasteiger, G. (2021) · Trillium Immunologie · doi:10.47184/ti.2021.02.03
TIRO CON ARCO: NUEVO EXAMEN PARA NUESTROS ARQUEROS
Ruiz, N. (2009)
Immunology and immunotherapy in CRC
Cordero, O. J., Varela‐Calviño, R., Graña-Suárez, B., & García-López, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90055-3.00031-4
Immunology and Immunotherapy of Colorectal Cancer
Cordero, O. J., Varela‐Calviño, R., & Graña-Suárez, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-57949-4_10
Faculty Opinions recommendation of Commensal bacteria protect against food allergen sensitization.
Eichenfield, L. F. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718544532.793551865
Alternative splicing takes charge of interleukin-22 and interferon lambda 4 signalingPreprint
Lim, C. (2018) · Thesis Commons (OSF Preprints) · doi:10.31237/osf.io/sca8k
Belz, G. T. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737396107.793575848
Interleukin-10 Superfamily and Cancer
Yuzhalin, A. E., & Kutikhin, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801121-8.00006-3
Wiest, D. L., & Contreras, A. V. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734991608.793573534
Inflammatory Biomarkers for Cancer
Corthay, A., & Haraldsen, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_12
Regulation of Cancer Development and Evolution by Innate Lymphoid Cells
Estrada, J. A., & Contreras, I. (2022) · Springer eBooks · doi:10.1007/978-3-030-80962-1_13-1
Advances in the Relationship between Interleukin-22 and Colonic Diseases
刘, 杏. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1351133
Геннадьевна, С. Е., Vologzhanin, D. A., Kamilova, Т. A., Голота, А. С., Калинина, Н. М., Lantukhov, D. V., & Shcherbak, S. G. (2023) · University therapeutic journal · doi:10.56871/utj.2023.70.70.002 · Cited by 1
Jou, E. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.036
AlChalabi, R., Al-Salmani, M. S., Shaban, S. A., & Suleiman, A. A. (2024) · South Asian Journal of Cancer · doi:10.1055/s-0044-1789589
“38,39 Additionally,inamurineHCCmodelgeneratedusingaspeci fi cHCC cell line, the overexpression of IL23 resulted in enhanced growth of HCC, demonstrating a dependence on IL17 for this effect, 40 underscoringtheintricaterelationshipbetweenthese cytokines and their consequential impact on HCC…”
Innate Lymphoid Cells in Cancer: Immunobiology and Immunotherapy
Sousa, L. M., Tralhão, J. G., Ferreira, M. M., & Rodrigues‐Santos, P. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_368
Regulation of Cancer Development and Evolution by Innate Lymphoid Cells
Estrada, J. A., & Contreras, I. (2025) · Springer eBooks · doi:10.1007/978-3-032-00749-0_13
Metadata
- Authors
- Kirchberger, S., Royston, D. J., Boulard, O., Thornton, E., Franchini, F., Szabady, R. L., Harrison, O., & Powrie, F.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Oxford (GB)
- Corresponding author
- Powrie, Fiona
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2013-04-15
- Volume
- 210
- Issue
- 5
- Pages
- 917-931
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3646494
- OpenAlex
- W2124499950
- Cited by
- 529
- References
- 52
- Citations by year
- 2026: 18 · 2025: 12 · 2024: 24 · 2023: 33 · 2022: 39 · 2021: 34 · 2020: 54 · 2019: 51 · 2018: 42 · 2017: 55 · 2016: 48 · 2015: 54 · 2014: 50 · 2013: 12
- FWCI
- 30.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Funders
- Royal College of Pathologists of Australasia
- Wellcome Trust (095688/Z/11/Z, 095688)
- Cancer Research UK (A7297, A11663)
- National Institute for Health and Care Research
- European Commission (223151)
- Jean Shanks Foundation
- Austrian Science Fund
- Genentech
- Biotechnology and Biological Sciences Research Council (BB/I005609/1)
- NIHR Oxford Biomedical Research Centre
- UCB Celltech
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- colon cancer, IL-22, IL-17, innate lymphoid cells, inflammatory bowel disease, STAT3 phosphorylation, epithelial cell proliferation, therapeutic target
- MeSH terms
- Interleukin-22, Animals, Antigens, Ly, Cell Transformation, Neoplastic, Colitis, Colon, Colonic Neoplasms, Disease Models, Animal, Epithelial Cells, Humans, Interleukins, Lymphocytes, Phosphorylation, CD4 Antigens, Gene Expression Regulation, Neoplastic, Helicobacter, Disease Progression, Cell Lineage, STAT3 Transcription Factor, Mice, Natural Cytotoxicity Triggering Receptor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.